Dr. Vu Duong, MD

Hospitalist Baltimore, MD Male
NPI: 1356563530
Total Payments
$18,998
2023 Payments
$1,089
Companies
6
Transactions
20
Medicare Patients
870
Medicare Billing
$205,267

Payment Breakdown by Category

Research$15,545 (81.8%)
Consulting$1,650 (8.7%)
Other$1,000.00 (5.3%)
Food & Beverage$803.52 (4.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $15,545 7 81.8%
Consulting Fee $1,650 1 8.7%
Compensation for serving as faculty or as a speaker for a medical education program $1,000 1 5.3%
Food and Beverage $803.52 11 4.2%

Payments by Type

Research
$15,545
7 transactions
General
$3,454
13 transactions

Top Paying Companies

Company Total Records Latest Year
NOVARTIS PHARMACEUTICALS CORPORATION $15,545 7 $0 (2018)
PFIZER INC. $1,800 2 $0 (2017)
Celgene Corporation $1,000 1 $0 (2023)
Amgen Inc. $380.80 3 $0 (2019)
Otsuka Pharmaceutical Co., Ltd. $150.62 3 $0 (2018)
Pharmacyclics LLC, An AbbVie Company $122.32 4 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $1,089 4 Celgene Corporation ($1,000)
2022 $32.97 1 Pharmacyclics LLC, an AbbVie Company ($32.97)
2019 $264.72 2 Amgen Inc. ($264.72)
2018 $11,683 5 NOVARTIS PHARMACEUTICALS CORPORATION ($11,497)
2017 $5,929 8 NOVARTIS PHARMACEUTICALS CORPORATION ($4,048)

All Payment Transactions

20 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/29/2023 Celgene Corporation — Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,000.00 General
09/12/2023 Pharmacyclics LLC, An AbbVie Company EPKINLY (Drug), IMBRUVICA Food and Beverage In-kind items and services $33.15 General
Category: ONCOLOGY
05/05/2023 Pharmacyclics LLC, An AbbVie Company IMBRUVICA (Drug) Food and Beverage In-kind items and services $22.12 General
Category: ONCOLOGY
02/01/2023 Pharmacyclics LLC, An AbbVie Company IMBRUVICA (Drug) Food and Beverage In-kind items and services $34.08 General
Category: ONCOLOGY
11/29/2022 Pharmacyclics LLC, an AbbVie Company IMBRUVICA (Drug) Food and Beverage In-kind items and services $32.97 General
Category: ONCOLOGY
12/07/2019 Amgen Inc. Kyprolis (Drug) Food and Beverage In-kind items and services $143.19 General
Category: Oncology
12/07/2019 Amgen Inc. Kyprolis (Biological) Food and Beverage In-kind items and services $121.53 General
Category: Oncology
12/02/2018 Amgen Inc. Kyprolis (Biological) Food and Beverage In-kind items and services $116.08 General
Category: Oncology
12/01/2018 Otsuka Pharmaceutical Co., Ltd. — Food and Beverage In-kind items and services $69.48 General
03/27/2018 NOVARTIS PHARMACEUTICALS CORPORATION EXJADE (Drug) — In-kind items and services $3,592.83 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY
01/31/2018 NOVARTIS PHARMACEUTICALS CORPORATION EXJADE (Drug) — In-kind items and services $4,311.40 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY
01/24/2018 NOVARTIS PHARMACEUTICALS CORPORATION EXJADE (Drug) — In-kind items and services $3,592.83 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY
12/29/2017 PFIZER INC. — Consulting Fee Cash or cash equivalent $1,650.00 General
12/11/2017 NOVARTIS PHARMACEUTICALS CORPORATION EXJADE (Drug) — In-kind items and services $1,675.75 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY
12/11/2017 NOVARTIS PHARMACEUTICALS CORPORATION EXJADE (Drug) — In-kind items and services $1,340.60 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY
12/09/2017 Otsuka Pharmaceutical Co., Ltd. — Food and Beverage In-kind items and services $40.57 General
12/09/2017 Otsuka Pharmaceutical Co., Ltd. — Food and Beverage In-kind items and services $40.57 General
12/07/2017 PFIZER INC. MYLOTARG (Drug) Food and Beverage In-kind items and services $149.78 General
Category: ONCOLOGY
08/01/2017 NOVARTIS PHARMACEUTICALS CORPORATION EXJADE (Drug) — In-kind items and services $573.00 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY
08/01/2017 NOVARTIS PHARMACEUTICALS CORPORATION EXJADE (Drug) — In-kind items and services $458.40 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
RESEARCH RELATED PUBLICATION SUPPORT NOVARTIS PHARMACEUTICALS CORPORATION $15,545 7

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 161 423 $120,940 $41,770
2022 8 208 541 $133,542 $49,205
2021 7 209 588 $146,670 $53,824
2020 8 292 706 $176,249 $60,468
Total Patients
870
Total Services
2,258
Medicare Billing
$205,267
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 30 138 $33,964 $13,894 40.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 36 109 $39,394 $13,114 33.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 52 117 $30,381 $8,962 29.5%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 18 18 $7,848 $2,532 32.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 27 $4,355 $1,679 38.6%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 14 14 $4,998 $1,588 31.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 50 267 $59,808 $22,504 37.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 32 70 $21,980 $8,449 38.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 48 102 $23,766 $7,981 33.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 30 32 $13,952 $5,296 38.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 12 30 $4,680 $1,758 37.6%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 11 11 $4,939 $1,572 31.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 14 18 $2,844 $969.73 34.1%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 11 11 $1,573 $675.21 42.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 49 248 $55,552 $21,384 38.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 55 166 $38,678 $13,770 35.6%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 32 89 $27,946 $9,797 35.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 28 31 $13,516 $4,837 35.8%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 14 14 $4,998 $1,565 31.3%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 19 20 $2,860 $1,240 43.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 12 20 $3,120 $1,231 39.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 51 196 $43,904 $17,225 39.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 49 177 $55,578 $16,488 29.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 38 138 $21,528 $8,232 38.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 38 41 $17,876 $6,786 38.0%
12»

About Dr. Vu Duong, MD

Dr. Vu Duong, MD is a Hospitalist healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356563530.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vu Duong, MD has received a total of $18,998 in payments from pharmaceutical and medical device companies, with $1,089 received in 2023. These payments were reported across 20 transactions from 6 companies. The most common payment nature is "" ($15,545).

As a Medicare-enrolled provider, Duong has provided services to 870 Medicare beneficiaries, totaling 2,258 services with total Medicare billing of $205,267. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Hospitalist
  • Other Specialties Internal Medicine, Hematology & Oncology
  • Location Baltimore, MD
  • Active Since 05/03/2007
  • Last Updated 10/16/2014
  • Taxonomy Code 208M00000X
  • Entity Type Individual
  • NPI Number 1356563530

Products in Payments

  • EXJADE (Drug) $15,545
  • Kyprolis (Biological) $237.61
  • MYLOTARG (Drug) $149.78
  • Kyprolis (Drug) $143.19
  • IMBRUVICA (Drug) $89.17
  • EPKINLY (Drug) $33.15

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hospitalist Doctors in Baltimore

Eric Ritter, Md, MD

Hospitalist — Payments: $55,557

Hospitalist $55,557

Francoise Marvel, Md, MD

Hospitalist — Payments: $47,167

Hospitalist $47,167

Mr. Felix Yelovich, Pa-C, PA-C

Hospitalist — Payments: $6,179

Hospitalist $6,179

Ajay Hooda, M.d, M.D

Hospitalist — Payments: $5,967

Hospitalist $5,967

Christopher Badger, Md, MD

Hospitalist — Payments: $5,036

Hospitalist $5,036

Oneib Khan, Md, MD

Hospitalist — Payments: $4,777

Hospitalist $4,777